Additional information
| Active substance | Fluoxetine |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low risk, but liver function tests are recommended during prolonged use |
| Lab Test | Monitoring plasma levels is not routinely required but can be done if overdose is suspected or for pharmacokinetic studies |
| Strength | 20 mg |
| Also known as | Prozac, fluoxetine hydrochloride |
| Blood pressure | Typically has minimal effect on blood pressure |
| Trade name | Prozac, Sarafem, among others |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (RS)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine |
| Formula | C17H18F3NO |
| Substance class | Selective Serotonin Reuptake Inhibitor (SSRI) |
| Main action | Inhibits the reuptake of serotonin in the brain |
| Half-life | 1 to 3 days for fluoxetine and 4 to 6 days for its active metabolite, norfluoxetine |
| Dosage (medical) | Typically 20 mg per day, may be adjusted based on response and tolerability |
| Dosage (sports) | Not applicable as it is not used to enhance athletic performance |
| Effects | Antidepressant, improves mood, sleep, appetite, and energy level |
| Side effects | Nausea, headache, dizziness, dry mouth, sweating, sleep disturbances, sexual dysfunction |
| Use in sports | None, as it does not enhance athletic performance |
| Manufacturer | Cadila Pharmaceuticals Ltd. |
| Packing | 15 caps/blister |
Prograf 1mg Astellas Pharma
Tavanic 500 mg Sanofi
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Balkan Pharma Oxandrolon 10 mg 60 Tabletten
Zimaks 400 Bilim
Zyban Glaxosmithkline 


Reviews
There are no reviews yet.